文献速递瓣膜外科先天性心脏病外科

15毫米机械瓣行二尖瓣置换的20年多中心经验

Mitral Valve Replacement With the 15-mm Mechanical Valve: A 20-Year Multicenter Experience.
PubMed 文献 · Ann Thorac Surg · 2020-01-18

该多中心回顾性队列研究评估了17例婴儿使用15-mm St Jude Medical机械瓣行二尖瓣置换的早期和长期结局。手术可在婴儿甚至新生儿中安全实施,因生长导致的假体更换中位时间为3.5年,血栓栓塞并发症罕见。

要点

  • 15-mm机械瓣可用于婴儿甚至新生儿的二尖瓣置换。
  • 因生长导致的假体更换中位无替换时间为3.5年。
  • 血栓栓塞并发症罕见,但假体跨瓣压差随随访时间增加。

核心结论

  • 婴儿甚至新生儿使用15-mm机械瓣行二尖瓣置换可安全实施。
  • 因生长导致的假体更换中位无替换时间为3.5年。
  • 血栓栓塞并发症罕见。

研究设计与样本

  • 多中心回顾性队列研究,纳入荷兰4个先天性心脏病中心接受15-mm St Jude Medical Masters机械瓣二尖瓣置换的患者。
  • 共17例婴儿接受手术,术前10例(59%)在ICU治疗,8例(47%)使用呼吸机。
  • 手术中位年龄3.2个月(IQR 1.2-5.6),中位体重5.2 kg(IQR 3.9-5.7)。
  • 术后0.5、1、2、3、5、10年进行超声心动图随访,中位随访9.6年(IQR 2.4-13.2),8例随访超过10年。

主要发现

  • 早期心脏死亡1例,晚期非心脏死亡1例。
  • 首次假体更换共11例,中位时间2.9年(IQR 2.0-5.4)。
  • 其他再干预包括永久起搏器植入3例、主动脉下狭窄切除2例、瓣周漏修复1例。
  • 假体跨瓣压差从出院时平均5.0 mmHg增至5年随访时平均14.3 mmHg。

临床怎么用

  • 对于需要二尖瓣置换的婴儿甚至新生儿,15-mm机械瓣是一种可考虑的选择。
  • 术后需规律超声随访监测假体跨瓣压差变化,并警惕因生长导致的假体更换需求。

局限性

  • 回顾性研究设计,样本量小(17例婴儿)。
  • 来自4个先天性心脏病中心的多中心经验,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to evaluate early and long-term outcomes (mortality and prosthetic valve replacement) after mitral valve replacement with the 15-mm St Jude Medical prosthesis (St Jude Medical, St Paul, MN). METHODS: A multicenter, retrospective cohort study was performed among patients who underwent mitral valve replacement with a 15-mm St Jude Medical Masters prosthesis at 4 congenital cardiac centers in The Netherlands. Operative results were evaluated and echocardiographic data studied at 0.5, 1, 2, 3, 5, and 10 years after surgery. RESULTS: Surgery was performed in 17 infants. Ten patients (59%) were treated in the intensive care unit before surgery; 8 (47%) were on ventilator support. Median age at surgery was 3.2 months (interquartile range [IQR], 1.2-5.6), and median weight was 5.2 kg (IQR 3.9-5.7). There was 1 early cardiac death and 1 late noncardiac death. Median follow-up time was 9.6 years (IQR, 2.4-13.2), including 8 patients with a follow-up more than 10 years. The first prosthetic valve explantation (n = 11) occurred at a median of 2.9 years (IQR, 2.0-5.4). Other reinterventions were permanent pacemaker implantation (n = 3), subaortic stenosis resection (n = 2), and paravalvular leak repair (n = 1). Prosthetic valve gradients increased from a mean of 5.0 mm Hg (at discharge) to a mean of 14.3 mm Hg (at 5-year follow-up). CONCLUSIONS: Mitral valve replacement with the 15-mm prosthesis can safely be performed in infants and even in neonates. Median freedom from prosthesis replacement for outgrowth is 3.5 years. Thromboembolic complications were rare.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. IJsselhof RJ, Slieker MG, Hazekamp MG, et al. Mitral Valve Replacement With the 15-mm Mechanical Valve: A 20-Year Multicenter Experience. Ann Thorac Surg. 2020. PMID: 31962116. doi:10.1016/j.athoracsur.2019.11.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。